Products

What will AGI do for Azamethonium bromide?

This classification denotes an antihypertensive agent with the molecular formula C13H33N3.2Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4K6NEI0MSR, chemically known as 3,3,6,9,9-pentamethyl-6-aza-3,9-diazoniaundecan dibromid but more generally known as azamethonium bromide, which bears US NIH Compound Identifier 9382. European Medicines Agency schedules Azamethonium bromide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05632MIG. The term AZAMETHONIUM BROMIDE is an International Non-Proprietary Name. Most nations, for tariff and trade purposes, schedule azamethonium bromide under HS 29239000 and SITC 51481. As of Q4 2014, AZAMETHONIUM BROMIDE remains US FDA's Preferred Term for this commodity. Azamethonium bromide bears US NLM identifiers UMLS ID C0104798 and NCI Concept Code C72971. SMILES: CC[N+](C)(C)CCN(C)CC[N+](C)(C)CC.[BR-].[BR-].

How AGI delivers it

Four ways AGI delivers for Azamethonium bromide

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Azamethonium bromide, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Azamethonium bromide, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Azamethonium bromide connects

measured by

  • Assay Puritymodel
  • Impurity Contentmodel
  • Loss On Dryingmodel